September 18, 2017 – Claret Medical announced publication of a new study in the...
Embolic Protection Devices
-
-
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel Cerebral Protection System (CPS), via de novo classification, enabling U.S.
-
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due to emboli released during the procedure.
-
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at Transcatheter Cardiovascular Therapeutics (TCT) 2015 showed the first definitive...
News | Embolic Protection Devices | September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
News | Embolic Protection Devices | September 07, 2017
September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection...
News | Embolic Protection Devices | August 23, 2017
August 23, 2017 — PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to...
Feature | Heart Valve Technology | June 09, 2017
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
News | Peripheral Artery Disease (PAD) | May 17, 2017
May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral...
News | Embolic Protection Devices | April 11, 2017
April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...
The CardioGard embolic protection system for surgical aortic valve replacement.
Feature | Embolic Protection Devices | March 22, 2017
March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...
News | Heart Valve Technology | February 28, 2017
February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...
News | Stents Carotid | November 18, 2016
November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a...
Videos | Heart Valve Technology | November 08, 2016
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage...
News | Heart Valve Technology | November 07, 2016
November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular...
News | Heart Valve Technology | November 07, 2016
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel...
News | Embolic Protection Devices | September 29, 2016
September 29, 2016 — Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral...
News | Embolic Protection Devices | September 20, 2016
September 20, 2016 – Claret Medical announced its filing of a marketing application with the U.S. Food and Drug...
The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.
Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...
